Schering-Plough’s Fred Hassan: An Interview With “The Pink Sheet”

After unveiling Schering-Plough's R&D pipeline in November, CEO Fred Hassan talked with "The Pink Sheet" in mid-December about balancing primary and specialty care portfolios, fixed-term limits for future FDA commissioners, licensing opportunities and more.